RxDoctor Payments Data

Donna Robertson

Family · Martinsville, VANPI 1144579921

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novo Nordisk at 26.3% of the total. 2025 is the largest year on record at $886, more than ten times the $17 reported in 2023.

$1,140in general payments, 2019–2025

Across 61 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$300
  • AbbVie$205
  • Johnson & Johnson$78
  • AstraZeneca$62
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$60
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
  • plus $375 from 14 others

What the payments were for

  • Food & beverage$1,140100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,140 in reported general payments places this provider in the 70th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone12$65
Azithromycin19$49
Amoxicillin14$25

Paid to pharmacies, not to this prescriber.

Other family in Martinsville

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →